Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets.It was founded in 2014 and is headquartered in Ann Arbor, Michigan.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 8, 2022 | Series B | $20M | 1 | — | — | Detail |
| Feb 15, 2022 | Grant | $1.70M | 1 |
National Institutes of Health
|
— | Detail |
| Apr 25, 2017 | Grant | $1.50M | 1 |
National Institutes of Health
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
Yes | Grant |
|
|
— | Series B |